![Alexandra Dietrich](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alexandra Dietrich
Director Ejecutivo en Syntacoll Gmbh .
Cargos activos de Alexandra Dietrich
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Syntacoll Gmbh
![]() Syntacoll Gmbh Pharmaceuticals: MajorHealth Technology Part of Innocoll Holdings Plc, Syntacoll GmbH is a German pharmaceutical company that develops and manufactures fully resorbable collagen-based implants. The company is based in Saal an der Donau, Germany and was founded in 1992. The CEOs are Alexandra Dietrich and Kimball Hall. Syntacoll is the only development and production site of Innocoll, and their products are manufactured according to GMP and ISO 13485 standards. The company holds a manufacturing license for active substance-containing drugs based on collagen. Syntacoll's mission is to provide innovative medical and pharmaceutical products for patient care, and their vision is to be recognized as one of the leading providers of medical and pharmaceutical products worldwide. The company values integrity, inclusion, collaboration, and responsibility. | Director Ejecutivo | 01/03/2007 | - |
Historial de carrera de Alexandra Dietrich
Formación de Alexandra Dietrich.
Ludwig-Maximilians-Universität München | Doctorate Degree |
Estadísticas
Internacional
Alemania | 3 |
Operativa
Doctorate Degree | 1 |
Chief Executive Officer | 1 |
Sectorial
Consumer Services | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Syntacoll Gmbh
![]() Syntacoll Gmbh Pharmaceuticals: MajorHealth Technology Part of Innocoll Holdings Plc, Syntacoll GmbH is a German pharmaceutical company that develops and manufactures fully resorbable collagen-based implants. The company is based in Saal an der Donau, Germany and was founded in 1992. The CEOs are Alexandra Dietrich and Kimball Hall. Syntacoll is the only development and production site of Innocoll, and their products are manufactured according to GMP and ISO 13485 standards. The company holds a manufacturing license for active substance-containing drugs based on collagen. Syntacoll's mission is to provide innovative medical and pharmaceutical products for patient care, and their vision is to be recognized as one of the leading providers of medical and pharmaceutical products worldwide. The company values integrity, inclusion, collaboration, and responsibility. | Health Technology |
- Bolsa de valores
- Insiders
- Alexandra Dietrich
- Experiencia